Gotenba, Japan

Haruhiko Sato

This inventor holds 16 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Kabushiki Kaisha Toshiba, Denki Kagaku Kogyo Kabushiki Kaisha. Active years: 1988-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruhiko Sato. Retrieved from https://idiyas.com/inventor/haruhiko-sato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 56.3

Average Co-Inventor Count = 5.3

ph-index = 6

Forward Citations = 136(Granted Patents)


Location History:

  • Hachioji, JP (1994)
  • Tokyo, JP (1988 - 1995)
  • Shizuoka-ken, JP (1997 - 1999)
  • Shizuoka, JP (1997 - 2006)
  • Gotenba, JP (2007 - 2013)

Company Filing History:


Years Active: 1988-2013

Loading Chart...
Areas of Expertise:
Imidazolidine Derivative
Hyaluronic Acid
Methotrexate Conjugate
Peptide Derivatives
Benzopyran Compounds
Furobenzisoxazole
Dioxolobenzizoxazole
Medicaments
Active Ingredient
Radio Tele-communication
Paging Apparatus
Clock Function
16 patents (USPTO):Explore Patents

Title: Haruhiko Sato: A Pioneer in Chemical Innovations

Introduction

Haruhiko Sato, an accomplished inventor based in Gotenba, Japan, holds an impressive portfolio of 16 patents. Known for his expertise in chemical compounds, Sato has significantly contributed to the field of medicinal chemistry, particularly with inventive solutions tailored for therapeutic applications.

Latest Patents

Among his notable innovations are the "Imidazolidine derivative and use thereof" and the "Hyaluronic acid-methotrexate conjugate." The imidazole derivative patent describes a unique chemical structure aimed at enhancing the efficacy of various applications, showcasing Sato's inclination towards practical and innovative solutions. The hyaluronic acid-methotrexate conjugate represents a significant advancement in therapies for joint diseases, wherein methotrexate is effectively linked to hyaluronic acid through a peptide chain, promising enhanced treatment options for patients.

Career Highlights

Throughout his career, Haruhiko Sato has collaborated with prominent companies such as Chugai Pharmaceutical Co., Ltd. and Toshiba Corporation. His work at these institutions has enabled him to harness valuable resources and expertise, further amplifying his contributions to innovative drug development.

Collaborations

Sato has partnered with esteemed colleagues, including Hiroshi Koga and Takenori Ishizawa. Their collective efforts have fostered a collaborative environment that encourages the sharing of insights and advancements in the realm of chemistry and pharmaceuticals.

Conclusion

Haruhiko Sato's pioneering work and substantial patent portfolio underscore his role as a leading innovator in the field of medicinal chemistry. His contributions not only reflect his profound understanding of chemical compounds but also his commitment to addressing complex health issues through innovative solutions. With his continuous work, Sato remains a significant figure in the landscape of chemical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…